Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Estey

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Leukemia|March 17, 2000
Treatment of relapsed and refractory acute myelogenous leukemiaE H Estey
Blood|August 29, 2000
How I treat older patients with AMLE H Estey
Oncology (Williston Park, N.Y.)|February 24, 1999
Incorporating new modalities into guidelines. Topotecan for myelodysplastic syndromesE H Estey
Leukemia|March 16, 2002
New drugs for therapy of AMLE H Estey
Leukemia|October 20, 1998
New agents for the treatment of acute myelogenous leukemia: focus on topotecan and retinoidsE H Estey
Haematologica|July 24, 1998
Prognosis and therapy of secondary myelodysplastic syndromesE H Estey
Leukemia|May 23, 2001
Prognostic factors in acute myelogenous leukemiaE H Estey
Leukemia|June 13, 2013
Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemiaE H Estey
Cancer Treatment and Research|January 1, 1993
Prognosis and therapy of myelodysplastic syndromesE H Estey
Leukemia|November 26, 2011
How to manage high-risk acute myeloid leukemiaE H Estey
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Leukemia|March 17, 2000
Treatment of relapsed and refractory acute myelogenous leukemiaE H Estey
Blood|August 29, 2000
How I treat older patients with AMLE H Estey
Oncology (Williston Park, N.Y.)|February 24, 1999
Incorporating new modalities into guidelines. Topotecan for myelodysplastic syndromesE H Estey
Leukemia|March 16, 2002
New drugs for therapy of AMLE H Estey
Leukemia|October 20, 1998
New agents for the treatment of acute myelogenous leukemia: focus on topotecan and retinoidsE H Estey
Haematologica|July 24, 1998
Prognosis and therapy of secondary myelodysplastic syndromesE H Estey
Leukemia|May 23, 2001
Prognostic factors in acute myelogenous leukemiaE H Estey
Leukemia|June 13, 2013
Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemiaE H Estey
Cancer Treatment and Research|January 1, 1993
Prognosis and therapy of myelodysplastic syndromesE H Estey
Leukemia|November 26, 2011
How to manage high-risk acute myeloid leukemiaE H Estey
Pageof 13